SNY - Sanofi

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in EUR. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue35,677,00036,221,00034,696,00034,861,000
Cost of Revenue11,321,00011,447,00010,701,00010,919,000
Gross Profit24,356,00024,774,00023,995,00023,942,000
Operating Expenses
Research Development5,894,0005,472,0005,172,0005,082,000
Selling General and Administrative9,934,00010,164,0009,592,0009,496,000
Non Recurring----
Others233,000-81,00021,000256,000
Total Operating Expenses29,552,00028,868,00027,178,00027,890,000
Operating Income or Loss6,125,0007,353,0007,518,0006,971,000
Income from Continuing Operations
Total Other Income/Expenses Net-1,221,000-1,737,000-1,707,000-1,750,000
Earnings Before Interest and Taxes6,125,0007,353,0007,518,0006,971,000
Interest Expense-471,000-346,000-360,000-331,000
Income Before Tax4,904,0005,616,0005,811,0005,221,000
Income Tax Expense481,0001,722,0001,325,000709,000
Minority Interest159,000169,000170,000161,000
Net Income From Continuing Ops4,423,0003,894,0004,486,0004,512,000
Non-recurring Events
Discontinued Operations-13,0004,643,000314,000-124,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,306,0008,416,0004,709,0004,287,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,306,0008,416,0004,709,0004,287,000